Virios Therapeutics (VIRI) Q3 2024 Earnings

8AugConfirmed
Q3 2023
Q4 2023
Q2 2024
Q3 2024
-1.58
-1.06
-0.53
0

Details

Expected EPS
-1.583333
Actual EPS
-1.25
Surprise EPS
0.33
Surprise Percent
+21.05%

Description

Virios Therapeutics (VIRI) has reported earnings of -1.25 per share for Q3 2024.

0 Comments

Share your thoughts